Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F4NP
|
|||
Former ID |
DNCL003123
|
|||
Drug Name |
JNJ-17305600
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Phase 1 | [1] | |
Company |
Johnson & Johnson Pharmaceutical Research & Development
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glycine transporter GlyT-1 (SLC6A9) | Target Info | Inhibitor | [2] |
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | NRF2 pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026554) | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 935). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.